Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piramal Pharma Solutions (PPS) is a leading global Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services across the entire drug life cycle. The company offers a comprehensive suite of solutions ranging from drug discovery and development to commercial manufacturing of drug substances (APIs) and drug products (finished dosage forms). PPS is particularly recognized for its expertise in complex modalities, including antibody-drug conjugates (ADCs), high-potency APIs, and specialized delivery systems like inhalation anesthesia. With a global network of facilities across North America, Europe, and India, the company serves a diverse client base of large pharmaceutical firms and emerging biotech companies. In addition to its CDMO services, the broader Piramal Pharma entity maintains a significant portfolio in complex hospital generics and consumer healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaSolutions.